Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 1, keine Gesamtzahl für „Synagis“
Suchtreffer
Begriffe & Kennungen
Palivizumab
Eintrag öffnenSynagis
Eintrag öffnenSynagis · 4.1 Therapeutic indications · 1
Eintrag öffnenSynagis · 4.3 Contraindications · 1
Eintrag öffnenSynagis · 4.3 · Hypersensitivity to the active substance or to any of the excipients listed in section 6.1, or to other humani
Eintrag öffnenSynagis · 4.4 Special warnings and precautions for use · 1
Eintrag öffnenSynagis · 4.5 Interaction with other medicinal products and other forms of interaction · 1
Eintrag öffnenSynagis · 4.5 · 3 vaccine, bronchodilators or corticosteroids were similar and no incremental increase in adverse reactions wa
Eintrag öffnenSynagis · 4.5 · No formal interactions studies with other medicinal products were conducted. In the phase III IMpact- RSV stud
Eintrag öffnenSynagis · 4.5 · Palivizumab may interfere with immune-based RSV diagnostic tests, such as some antigen detection based assays.
Eintrag öffnenSynagis · 4.5 · Since the monoclonal antibody is specific for RSV, palivizumab is not expected to interfere with the immune re
Eintrag öffnenSynagis · 4.6 Fertility, pregnancy and lactation · 1
Eintrag öffnenSynagis · 4.8 Undesirable effects · 1
Eintrag öffnenSynagis · 4.8 · 4 Undesirable effects in clinical studies* and post-marketing reports in paediatric patients MedDRA system org
Eintrag öffnenSynagis · 4.8 · Description of selected adverse reactions Post-marketing experience Post-marketing serious spontaneous adverse
Eintrag öffnenSynagis · 4.8 · In a small open label prospective trial of 14 subjects, who received 6 doses, the adverse events reported were
Eintrag öffnenSynagis · 4.8 · In an observational, post-marketing, database study, a small increase in the frequency of asthma was observed
Eintrag öffnenSynagis · 4.8 · Palivizumab treatment schedule and adverse reactions were monitored in a group of nearly 20,000 infants tracke
Eintrag öffnenSynagis · 4.8 · Reporting of suspected adverse reactions Reporting suspected adverse reactions after authorisation of the medi
Eintrag öffnenSynagis · 4.8 · Summary of the safety profile The most serious adverse reactions occurring with palivizumab are anaphylaxis an
Eintrag öffnen